Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stereospecific Detection Technologies (SDT) is a specialized biotechnology company based in Germany that develops and manufactures high-performance reagents for immunoassays, nucleic acid hybridization, and immunohistochemistry. Founded in 1996, the company is a leading bulk OEM supplier to the in vitro diagnostics (IVD) industry and pharmaceutical drug discovery programs. SDT is best known for its proprietary Poly-HRP (Polymeric Horseradish Peroxidase) technology, which enables ultra-sensitive detection in ELISA and blotting applications with picogram to femtogram sensitivity. The company's portfolio includes specialized conjugates, stabilizers, and substrates designed to enhance assay sensitivity and robustness for life science research and clinical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SDT.